INVERSAGO-PHARMA-INC.
29.9.2020 14:02:30 CEST | Business Wire | Press release
Inversago Pharma Inc. (“the Company” or “Inversago”), the peripheral CB1 blockade company, today announced it has initiated a Phase 1 clinical trial of INV-101, the Company’s peripherally-acting CB1 blocker, which is being developed for the treatment of Prader-Willi syndrome (PWS) and non-alcoholic steatohepatitis (NASH).
The trial will evaluate the safety, tolerability and pharmacokinetics of INV-101. Recruitment is ongoing and will enroll healthy participants in Canada, from 18 to 55 years old. Subjects will initially be randomized to receive a single dose of placebo or one of 5 dose levels of INV-101.
“With the launch of this first-in-human trial, Inversago is now a clinical-stage company, and confirms its lead in the comeback of small molecule peripheral CB1 blockers”, said François Ravenelle, PhD, CEO and founder of Inversago Pharma.
“Dosing of our first patient with INV-101 represents an important milestone to accomplish the Company’s vision: offering a potentially meaningful therapeutic option to underserved patient populations, like in PWS and NASH" said Carlo Incerti, M.D., Chairman of the Board of Inversago. "This study is the first step in the clinical development of our peripherally-acting CB1 blockers, and we expect it to provide important information about its safety and pharmacokinetics profile", concluded Dr. Incerti.
The Company’s second program, INV-202, is presently in IND-enabling preclinical studies, while other programs are in earlier stages of development. With its current pipeline, Inversago is well positioned to fully exploit peripheral CB1 blockade for a wide range of underserved metabolic indications with differentiated products.
About INV-101
INV-101 is a first-in-class, small molecule CB1 inverse agonist / antagonist being developed by Inversago for the treatment of PWS and NASH. It is specifically designed to interact with peripheral CB1 receptors located in the gastro-intestinal tract, liver, pancreas, adipose tissues, muscles, lungs and other organs, thus aiming at a safe and effective therapeutic approach without the known liabilities of centrally-acting CB1 blockers. The peripheral CB1 blockade is a well-documented pathway, linked to many clinically meaningful metabolic benefits.
About Inversago Pharma
Inversago Pharma is a clinical-stage, biotech company specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting CB1 inverse agonists. The Company aims to provide new treatment options that improve the lives of patients affected by metabolic conditions such as Prader-Willi Syndrome (PWS), non-alcoholic steatohepatitis (NASH), type 1 diabetes (T1D) and diabetic nephropathy. For more information, visit inversago.com .
Picture of our CEO and company logotype available for download at: inversago.com/en/media/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200929005408/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Audiencerate: Riccardo Fabbri Joins as Chief Technology Officer—The AI-Driven Phase of the Platforms for SMEs and Media Agencies Begins21.5.2026 09:00:00 CEST | Press release
The co-founder and former managing partner of Nohup (acquired by Havas Group in 2021) will lead the development of the artificial intelligence infrastructure that integrates first-party and third-party data, powering the platform delivered with Postel and Microsoft to Italian SMEs and the platform with the DV360 offering for global media agencies. Audiencerate Ltd, one of the few globally certified Google Customer Match Upload Partners and a Microsoft IP Co-sell certified partner with MACC eligibility, today announced the appointment of Riccardo Fabbri as Chief Technology Officer. The appointment marks a phase of dual expansion: the Audiencerate–Postel–Microsoft platform for Italian SMEs, and the Data platform integrated with Google DV360 for Agencies and Data Providers — both evolving toward a model that natively leverages first-party and third-party data through AI and machine learning. This press release features multimedia. View the full release here: https://www.businesswire.com/n
Phison's Pascari Enterprise Storage Honored with COMPUTEX Best Choice Golden Award for Breakthrough 245.76 TB Capacity21.5.2026 08:30:00 CEST | Press release
Latest PCIe Gen5 SSD lowers costs at scale for optimized data center OPEX Phison Electronics (8299TT), a global leader in NAND flash controllers and storage solutions, today announced that its Pascari D206V PCIe Gen5 data center SSD has received the prestigious COMPUTEX Best Choice Golden Award, recognizing the next generation of innovation in ultra-high-capacity enterprise storage for AI and modern data center infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260520865786/en/ Pascari D206V Wins COMPUTEX Best Choice Golden Award in 2026 The Pascari D206V is designed to address the growing industry challenge of efficiently scaling storage capacity for AI, cloud and data-intensive workloads without increasing operational complexity or infrastructure costs. Delivering up to 245.76 TB in a single U.2 PCIe Gen5 SSD, the D206V enables hyperscale and enterprise customers to significantly increase storage density while
Truecaller Travel eSIM Launch Powered by Telness Tech’s Seamless OS21.5.2026 08:30:00 CEST | Press release
Telness Tech, the telecom software company behind Seamless OS, today announced that Truecaller’s newly launched Travel eSIM service is powered by its platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260520906699/en/ Telness Tech, the telecom software company behind Seamless OS, today announced that Truecaller’s newly launched Travel eSIM service is powered by its platform. Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, has launched Travel eSIM across 29 countries, marking the company’s move into mobile data services. The launch broadens Truecaller’s platform beyond caller ID and spam protection, and for the first time adds digital consumables to the portfolio. With more than 500 million people already using Truecaller in their daily communication, Travel eSIM extends that relationship to international travel — a category where users routinely overpay for connectivi
AHS Properties: At 26, Abbas Sajwani Is Deploying Billions Into Dubai’s Future21.5.2026 08:00:00 CEST | Press release
Named the youngest billionaire in real estate globally by Forbes, the AHS Properties founder is scaling a AED 50 billion pipeline on a single conviction: Dubai is no longer a luxury market - it’s a capital destination. While global real estate capital recalibrates, Abbas Sajwani is accelerating. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519804834/en/ Abbas Sajwani, Founder and CEO of AHS Properties. (Photo: AETOSWire) The 26-year-old Founder and CEO of AHS Properties - recently recognised by Forbes as the youngest Arab billionaire and the youngest billionaire globally in real estate, with a net worth of $1.9 billion - is building one of the fastest-scaling development platforms in Dubai. Since launching in 2021, AHS Properties has expanded from ultra-luxury villa redevelopments into a multi-billion-dollar portfolio spanning waterfront residential, Grade-A commercial, and large-scale mixed-use developments across Duba
Xsolla and the Dubai Films and Games Commission Create a Strategic Partnership to Connect Dubai-Based Developers to Global Markets21.5.2026 05:16:00 CEST | Press release
Multi-Year Agreement Creates Opportunities to Build All The Things for Video Games in Dubai and MENA Xsolla, a leading global video game commerce company, and the Dubai Games Commissioner, in coordination with the Dubai Films and Games Commission, announced a multi-year strategic partnership to accelerate the development of the video game industry and expand commercial access for developers operating across the Middle East and North Africa. The announcement was made at GamesBeat Summit 2026 in Los Angeles, California. The partnership will unite Xsolla's global commerce infrastructure, including direct-to-consumer storefronts, intelligent payments across 1,000+ payment methods in 200+ geographies, and player engagement tools, with DFGC's mandate to establish Dubai as a world-class destination for video game development and publishing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260520329315/en/ Xsolla and the DFGC partner
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom